Pursuing a passion for public health
MIT senior Srihitha Dasari reflects on the power of experiential learning through the PKG Center for Social Impact.
MIT senior Srihitha Dasari reflects on the power of experiential learning through the PKG Center for Social Impact.
The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
By showing the problem derives from genetic mutations that lead to overexpression of a microRNA, MIT researchers’ study points to potential treatment.
Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.
In STS.059 (The Bioeconomy and Society), students explore the social and political factors at work in the biology, biotech, and biological engineering sectors.
Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.
WITEC is working to develop the first wearable ultrasound imaging system to monitor chronic conditions in real-time, with the goal of enabling earlier detection and timely intervention.
The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.
New research detects hidden evidence of mistaken correlations — and provides a method to improve accuracy.
New research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.
The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.
Using a versatile problem-solving framework, researchers show how early relapse in lymphoma patients influences their chance for survival.
The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.